State of the Science in Women's Cardiovascular Disease: A Canadian Perspective on the Influence of Sex and Gender
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Cardiovascular disease (CVD) is the leading cause of premature death for women in Canada. Although it has long been recognized that estrogen impacts vascular responses in women, there is emerging evidence that physiologic and pathophysiologic cardiovascular responses are uniquely affected across the spectrum of a woman's life. Despite a global understanding that manifestations and outcomes of CVD are known to differ between men and women, uptake of the recognition of sex and gender influences on the clinical care of women has been slow or absent.\n\nTo highlight the need for better research, diagnosis, treatment, awareness, and support of women with CVD in Canada, the Canadian Women's Heart Health Alliance (CWHHA), supported by the University of Ottawa Heart Institute, and in collaboration with the Heart and Stroke Foundation of Canada (HSFC), undertook a comprehensive review of the evidence on sex‐ and gender‐specific differences in comorbidities, risk factors, disease awareness, presentation, diagnosis, and treatment across the entire spectrum of CVD. The intent of this review was not to directly compare women and men on epidemiological and outcome measures of CVD, but to synthesize the state of the evidence for CVD in women and identify significant knowledge gaps that hinder the transformation to clinical practice and care that is truly tailored for women, a significant health challenge that has only been recognized in Canada relatively recently. This review highlights the scarcity of Canadian data on CVD in women as part of the ongoing struggle to increase awareness of and improve outcomes for women with CVD. Because of a paucity of published Canada‐specific evidence, the purpose of this review is to provide an infrastructure to summarize world‐wide published evidence, including knowledge gaps that must be understood to then make effective recommendations to alleviate the glaring “unders” of CVD for women in Canada: under‐aware, under‐diagnosed and under‐treated, under‐researched, and under‐support.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Child abuse: Adolescent records vs. adult recall
Femina, D. D., Yeager, C. A., & Lewis, D. O. (1990) · Child Abuse & Neglect · doi:10.1016/0145-2134(90)90033-p · Cited by 8,820
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Smith, C. R., Leon, M. B., Mack, M. J., Miller, D. C., Moses, J. W., Svensson, L. G., Tuzcu, E. M., Webb, J. G., Fontana, G. P., Makkar, R. R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103510 · Cited by 6,345
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Naghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32152-9 · Cited by 4,821
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Why is depression more prevalent in women?
Albert, P. R. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150205 · Cited by 1,785 · cited 1×
“Depression • Incidence is 2 times higher in women than in men.(24,25) • Increases a women’s risk for a cardiac event by 50% to 70%(26,27) and correlates with fatal cardiac events in postmenopausal women.”
BackgroundDepression and cardiovascular disease: a clinical review
Hare, D. L., Toukhsati, S. R., Johansson, P., & Jaarsma, T. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht462 · Cited by 1,362
Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association
Mehta, L. S., Beckie, T. M., DeVon, H. A., Grines, C. L., Krumholz, H. M., Johnson, M. N., Lindley, K. J., Vaccarino, V., Wang, T. Y., Watson, K. E., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000351 · Cited by 1,244
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Persons with disabilities as an unrecognized health disparity population
Krahn, G. L., Walker, D. K., & Correa-De-Araujo, R. (2015) · American Journal of Public Health · doi:10.2105/ajph.2014.302182 · Cited by 1,080
Update on acute coronary syndromes: the pathologists' view
Falk, E., Nakano, M., Bentzon, J. F., Finn, A. V., & Virmani, R. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs411 · Cited by 1,047 · cited 2×
“In most women with ACS, the underlying mechanism is similar to men because of the formation of thrombus caused by a rupture of atherosclerotic plaque.(65) However, women, especially younger women, are more likely to present with plaque erosion, where a discontinuation of the endothelium without evidence of fibrous cap…”
BackgroundHachicha, Z., Dumesnil, J. G., Bogaty, P., & Pibarot, P. (2007) · Circulation · doi:10.1161/circulationaha.106.668681 · Cited by 959 · cited 1×
“Low flow rate in aortic stenosis, despite a normal ejection fraction (ie, paradoxical low flow), is reportedly higher in women.(137) The impact of low flow reduces aortic valve velocity and gradient despite severe aortic stenosis, thus underestimating aortic stenosis severity and creating a dilemma in clinical managem…”
BackgroundThe prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis
Matcham, F., Rayner, L., Steer, S., & Hotopf, M. (2013) · Rheumatology · doi:10.1093/rheumatology/ket169 · Cited by 928
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Sex Differences in Autoimmune Disease from a Pathological Perspective
Fairweather, D., Frisancho-Kiss, S., & Rose, N. R. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071008 · Cited by 629
Grandi, S. M., Filion, K. B., Yoon, S., Ayele, H. T., Doyle, C. M., Hutcheon, J. A., Smith, G. N., Gore, G. C., Ray, J. G., Nerenberg, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036748 · Cited by 610 · cited 3×
“Hypertensive disorders of pregnancy, gestational diabetes mellitus, preterm birth, and infertility are independent sex-specific CVD risk factors associated with subsequent premature atherosclerotic CVD, arrhythmia, and HF.49 Premature menopause occurs before the age of 40 years and may be spontaneous as a result of pr…”
BackgroundInfluentialSelf-citationThe Complex Nature of Discordant Severe Calcified Aortic Valve Disease Grading
Clavel, M.-A., Messika-Zeitoun, D., Pibarot, P., Aggarwal, S. R., Malouf, J., Araoz, P. A., Michelena, H. I., Cueff, C., Larose, E., Capoulade, R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1621 · Cited by 569
Self-citationMeijer, A., Conradi, H. J., Bos, E. H., Thombs, B. D., van Melle, J. P., & de Jonge, P. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.02.007 · Cited by 547
Superior Vena Cava Defibrillator Coils Make Transvenous Lead Extraction More Challenging and Riskier
Epstein, L. M., Love, C. J., Wilkoff, B. L., Chung, M. K., Hackler, J. W., Bongiorni, M. G., Segreti, L., Carrillo, R. G., Baltodano, P., Fischer, A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.014 · Cited by 467
Emdin, C. A., Wong, C. X., Hsiao, A. J., Altman, D. G., Peters, S. A., Woodward, M., & Odutayo, A. A. (2016) · BMJ · doi:10.1136/bmj.h7013 · Cited by 452 · cited 1×
“Hypertension and AF are more frequent among women with stroke; AF is a major preventable cardiac cause of stroke and the risk is twice as high in women compared with men.(93)”
BackgroundHerrmann, H. C., Pibarot, P., Hueter, I., Gertz, Z. M., Stewart, W. J., Kapadia, S., Tuzcu, E. M., Babaliaros, V., Thourani, V., Szeto, W. Y., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.001290 · Cited by 433
Mason, J. C., & Libby, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu403 · Cited by 420
Vgontzas, A. N., Legro, R. S., Bixler, E. O., Grayev, A., Kales, A., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7185 · Cited by 371
Sex and Gender Differences in Myocarditis and Dilated Cardiomyopathy
Fairweather, D., Cooper, L. T., & Blauwet, L. A. (2013) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.07.003 · Cited by 325
Aggarwal, S. R., Clavel, M.-A., Messika-Zeitoun, D., Cueff, C., Malouf, J., Araoz, P. A., Mankad, R., Michelena, H., Vahanian, A., & Enriquez-Sarano, M. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.980052 · Cited by 280
Self-citationBotha, T. C., Pilcher, G. J., Wolmarans, K., Blom, D. J., & Raal, F. J. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.05.038 · Cited by 70 · cited 1×
“• Statin therapy during pregnancy for LDL-C reduction is reported to be safe for mother and fetus.(116)”
BackgroundMahmoudpour, S. H., Baranova, E. V., Souverein, P. C., Asselbergs, F. W., de Boer, A., Maitland‐van der Zee, A. H., & on behalf of the PREDICTION‐ADR consortium (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13090 · Cited by 40 · cited 1×
“7 times more likely to be ACE inhibitor intolerant.(105) • ACE inhibitors and ARBs are pregnancy category C (animal studies have shown an adverse effect on the fetus) for the first trimester of pregnancy and are category D (human fetal risk has been shown) during the second and third trimesters(78) ARBs • Maximum seru…”
Background
Cited by
Roeters van Lennep, J. E., Tokgözoğlu, L. S., Badimon, L., Dumanski, S. M., Gulati, M., Hess, C. N., Holven, K. B., Kavousi, M., Kayıkçıoğlu, M., Lutgens, E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad472 · Cited by 229
Self-citationFleury, M.-A., & Clavel, M.-A. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.02.003 · Cited by 58
Self-citationInvestigating the Effects of Sex Hormones on Macrophage Polarization
Enright, S., & Werstuck, G. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020951 · Cited by 37
Metadata
- Authors
- Norris, C. M., Yip, C. Y. Y., Nerenberg, K. A., Clavel, M., Pacheco, C., Foulds, H. J. A., Hardy, M., Gonsalves, C. A., Jaffer, S., Parry, M., Colella, T. J. F., Dhukai, A., Grewal, J., Price, J. A. D., Levinsson, A. L. E., Hart, D., Harvey, P. J., Van Spall, H. G. C., Sarfi, H., Sedlak, T. L., Ahmed, S. B., Baer, C., Coutinho, T., Edwards, J. D., Green, C. R., Kirkham, A. A., Srivaratharajah, K., Dumanski, S., Keeping‐Burke, L., Lappa, N., Reid, R. D., Robert, H., Smith, G., Martin‐Rhee, M., & Mulvagh, S. L.
- Venue
- Journal of the American Heart Association
- Published
- 2020-02-18
- Volume
- 9
- Issue
- 4
- Pages
- e015634-e015634
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W3006826074
- Cited by
- 188
- References
- 33
- FWCI
- 21.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.